The Warburg effect: insights from the past decade

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Otto Warburg's discovery of aerobic glycolysis in cancer cells, known as the Warburg effect.
• Initial decline in interest due to lack of evidence for mitochondrial defects, later revived by FDG-PET imaging.
• Ongoing debate on whether the Warburg effect is a cause or consequence of tumorigenesis.

Purpose of the Study:

• To review the molecular mechanisms underlying the Warburg effect in cancer.
• To highlight recent advancements, including the roles of epigenetics, miRNAs, and protein modifications.
• To discuss novel therapeutic strategies targeting cancer's altered energy metabolism.

Main Methods:

• Review of existing scientific literature on the Warburg effect.
• Emphasis on recent molecular and epigenetic findings.
• Discussion of emerging therapeutic approaches.

Main Results:

• Significant progress in understanding the Warburg effect's molecular underpinnings.
• Identification of key roles for epigenetic changes, miRNAs, and post-translational modifications.
• Emerging therapeutic strategies targeting cancer's glycolytic dependency show promise.

Conclusions:

• The Warburg effect remains a central topic in cancer metabolism research.
• Epigenetic factors, miRNAs, and protein modifications are crucial in regulating aerobic glycolysis.
• Targeting cancer's altered energy metabolism offers a promising avenue for novel therapies.